Seelos Therapeutics, Inc. (SEELQ)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 28, 2026
Seelos Therapeutics Market Cap
Seelos Therapeutics has a market cap or net worth of $1 as of November 11, 2026. It is the 53,403rd most valuable company in the world and the 9,325th biggest in the United States. Its market cap has decreased by 99.26% in one year.
Market Cap
1.00
Enterprise Value
n/a
Revenue
2.01M
Global Rank
Country Rank
#9,325 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since January 24, 2019, Seelos Therapeutics's market cap has decreased from 23.95M to 1.00, a decrease of -100.00%. That is a compound annual growth rate of -88.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 1.00 | - |
| Dec 31, 2025 | 1.00 | -100.00% |
| Dec 31, 2024 | 101.27K | -99.26% |
| Dec 29, 2023 | 13.61M | -81.29% |
| Dec 30, 2022 | 72.77M | -57.68% |
| Dec 31, 2021 | 171.95M | 103.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HAVN Life Sciences | 29.00 |
| Neurobiological Technologies | 27.00 |
| TetraLogic Pharmaceuticals | 24.00 |
| Verde Science | 24.00 |
| Sienna Biopharmaceuticals | 23.00 |
| 9 Meters Biopharma | 14.00 |
| PhaseRx | 12.00 |
| ContraFect | 11.00 |